These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15271950)

  • 1. Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells.
    Keller CC; Kremsner PG; Hittner JB; Misukonis MA; Weinberg JB; Perkins DJ
    Infect Immun; 2004 Aug; 72(8):4868-73. PubMed ID: 15271950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism.
    Keller CC; Hittner JB; Nti BK; Weinberg JB; Kremsner PG; Perkins DJ
    Mol Med; 2004; 10(1-6):45-54. PubMed ID: 15502882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.
    Awandare GA; Ouma Y; Ouma C; Were T; Otieno R; Keller CC; Davenport GC; Hittner JB; Vulule J; Ferrell R; Ong'echa JM; Perkins DJ
    Infect Immun; 2007 Jan; 75(1):201-10. PubMed ID: 17060471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interleukin-12 in malaria-tolerant papua new guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity.
    Boutlis CS; Lagog M; Chaisavaneeyakorn S; Misukonis MA; Bockarie MJ; Mgone CS; Wang Z; Morahan G; Weinberg JB; Udhayakumar V; Anstey NM
    Infect Immun; 2003 Nov; 71(11):6354-7. PubMed ID: 14573655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.
    Hobbs MR; Udhayakumar V; Levesque MC; Booth J; Roberts JM; Tkachuk AN; Pole A; Coon H; Kariuki S; Nahlen BL; Mwaikambo ED; Lal AL; Granger DL; Anstey NM; Weinberg JB
    Lancet; 2002 Nov; 360(9344):1468-75. PubMed ID: 12433515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide bioavailability in malaria.
    Sobolewski P; Gramaglia I; Frangos J; Intaglietta M; van der Heyde HC
    Trends Parasitol; 2005 Sep; 21(9):415-22. PubMed ID: 16039159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults.
    Boutlis CS; Tjitra E; Maniboey H; Misukonis MA; Saunders JR; Suprianto S; Weinberg JB; Anstey NM
    Infect Immun; 2003 Jul; 71(7):3682-9. PubMed ID: 12819048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent effect of plasma nitric oxide on parasite density in Ghanaian children with severe malaria.
    Cramer JP; Nüssler AK; Ehrhardt S; Burkhardt J; Otchwemah RN; Zanger P; Dietz E; Gellert S; Bienzle U; Mockenhaupt FP
    Trop Med Int Health; 2005 Jul; 10(7):672-80. PubMed ID: 15960706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia.
    Keller CC; Yamo O; Ouma C; Ong'echa JM; Ounah D; Hittner JB; Vulule JM; Perkins DJ
    Infect Immun; 2006 Sep; 74(9):5249-60. PubMed ID: 16926419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria.
    Perkins DJ; Kremsner PG; Schmid D; Misukonis MA; Kelly MA; Weinberg JB
    Infect Immun; 1999 Sep; 67(9):4977-81. PubMed ID: 10456963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population.
    Boutlis CS; Hobbs MR; Marsh RL; Misukonis MA; Tkachuk AN; Lagog M; Booth J; Granger DL; Bockarie MJ; Mgone CS; Levesque MC; Weinberg JB; Anstey NM
    Am J Trop Med Hyg; 2003 Dec; 69(6):569-73. PubMed ID: 14740870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model.
    Awandare GA; Kempaiah P; Ochiel DO; Piazza P; Keller CC; Perkins DJ
    Am J Hematol; 2011 Feb; 86(2):155-62. PubMed ID: 21264897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.
    Awandare GA; Hittner JB; Kremsner PG; Ochiel DO; Keller CC; Weinberg JB; Clark IA; Perkins DJ
    Clin Immunol; 2006 May; 119(2):219-25. PubMed ID: 16461006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-alpha: association with the pathogenesis of childhood malarial anemia.
    Keller CC; Davenport GC; Dickman KR; Hittner JB; Kaplan SS; Weinberg JB; Kremsner PG; Perkins DJ
    J Infect Dis; 2006 May; 193(10):1384-93. PubMed ID: 16619186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2).
    Perkins DJ; St Clair EW; Misukonis MA; Weinberg JB
    Arthritis Rheum; 1998 Dec; 41(12):2205-10. PubMed ID: 9870877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of nitric oxide synthase and activation of signaling proteins in Anopheles mosquitoes by the malaria pigment, hemozoin.
    Akman-Anderson L; Olivier M; Luckhart S
    Infect Immun; 2007 Aug; 75(8):4012-9. PubMed ID: 17526741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria.
    Kun JF; Mordmüller B; Perkins DJ; May J; Mercereau-Puijalon O; Alpers M; Weinberg JB; Kremsner PG
    J Infect Dis; 2001 Aug; 184(3):330-6. PubMed ID: 11443559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients.
    St Clair EW; Wilkinson WE; Lang T; Sanders L; Misukonis MA; Gilkeson GS; Pisetsky DS; Granger DI; Weinberg JB
    J Exp Med; 1996 Sep; 184(3):1173-8. PubMed ID: 9064335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of reduced LAIR1 expression in childhood severe malarial anaemia: Implications for leukocyte inhibitory signalling.
    Achieng AO; Guyah B; Cheng Q; Ong'echa JM; Ouma C; Lambert CG; Perkins DJ
    EBioMedicine; 2019 Jul; 45():278-289. PubMed ID: 31257148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria.
    Levesque MC; Hobbs MR; Anstey NM; Vaughn TN; Chancellor JA; Pole A; Perkins DJ; Misukonis MA; Chanock SJ; Granger DL; Weinberg JB
    J Infect Dis; 1999 Dec; 180(6):1994-2002. PubMed ID: 10558957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.